These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 20579007

  • 41. Selective mu- and kappa-opioid receptor antagonists administered into the nucleus accumbens interfere with rapid tolerance to ethanol in rats.
    Varaschin RK, Morato GS.
    Psychopharmacology (Berl); 2009 Sep; 206(1):85-96. PubMed ID: 19506836
    [Abstract] [Full Text] [Related]

  • 42. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM, Shen KF.
    Brain Res; 2007 Sep 05; 1167():31-41. PubMed ID: 17692296
    [Abstract] [Full Text] [Related]

  • 43. Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.
    Walker BM, Valdez GR, McLaughlin JP, Bakalkin G.
    Alcohol; 2012 Jun 05; 46(4):359-70. PubMed ID: 22459870
    [Abstract] [Full Text] [Related]

  • 44. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
    Rorick-Kehn LM, Witkin JM, Statnick MA, Eberle EL, McKinzie JH, Kahl SD, Forster BM, Wong CJ, Li X, Crile RS, Shaw DB, Sahr AE, Adams BL, Quimby SJ, Diaz N, Jimenez A, Pedregal C, Mitch CH, Knopp KL, Anderson WH, Cramer JW, McKinzie DL.
    Neuropharmacology; 2014 Feb 05; 77():131-44. PubMed ID: 24071566
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.
    Long JB, Rigamonti DD, de Costa B, Rice KC, Martinez-Arizala A.
    Brain Res; 1989 Sep 11; 497(1):155-62. PubMed ID: 2571391
    [Abstract] [Full Text] [Related]

  • 47. Effects of nor-binaltorphimine on butorphanol dependence.
    Jaw SP, Makimura M, Hoskins B, Ho IK.
    Eur J Pharmacol; 1993 Aug 03; 239(1-3):133-40. PubMed ID: 8223888
    [Abstract] [Full Text] [Related]

  • 48. Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naive rats.
    Kuzmin AV, Gerrits MA, Van Ree JM.
    Eur J Pharmacol; 1998 Oct 09; 358(3):197-202. PubMed ID: 9822884
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S, Suzuki T, Misawa M, Nagase H.
    Eur J Pharmacol; 1999 Feb 26; 368(1):9-16. PubMed ID: 10096764
    [Abstract] [Full Text] [Related]

  • 51. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
    Takemori AE, Schwartz MM, Portoghese PS.
    J Pharmacol Exp Ther; 1988 Dec 26; 247(3):971-4. PubMed ID: 2849679
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice.
    Mendizábal V, Zimmer A, Maldonado R.
    Neuropsychopharmacology; 2006 Sep 26; 31(9):1957-66. PubMed ID: 16292318
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes.
    Spanagel R, Almeida OF, Shippenberg TS.
    Eur J Pharmacol; 1994 Oct 24; 264(2):157-62. PubMed ID: 7851478
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M, Goldberg SR.
    Psychopharmacology (Berl); 2005 Jun 24; 179(4):804-12. PubMed ID: 15619107
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
    Durham RA, Johnson JD, Moore KE, Lookingland KJ.
    Brain Res; 1996 Sep 02; 732(1-2):113-20. PubMed ID: 8891275
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.